04/21/2026
It’s easy to dismiss Utah’s latest artificial intelligence experiment as dangerous and dystopian. The state has partnered with a company called Doctronic to empower an “AI doctor,” rather than a human clinician, to refill medication prescriptions.
But the idea deserves serious consideration. Deployed carefully, this innovation could improve access to care and reduce costs, even as it raises legitimate ethical and regulatory concerns.
My latest Washington Post column is about Utah’s pilot. It features interviews with Doctronic's cofounders as well as experts who take a more guarded approach.
For instance, Daniel Aaron, a physician and associate law professor at the University of Utah, noted that the US has long required medical devices to demonstrate safety and effectiveness before widespread use.
“To have this incredibly novel use of a medical device without FDA saying a word is quite stunning and suggests that maybe we are going to see more untested products reach the market,” he said.
More: https://wapo.st/4vEuI4M
Utah’s experiment with AI-generated prescriptions won’t be the last. It raises urgent regulatory questions that needs answers.